Skip to content

Establishment of [¹8F]Aldoview PET/CT Methodology and Its Clinical Value in the Diagnosis and Prognosis of Primary Aldosteronism

Establishment of [¹8F]Aldoview PET/CT Methodology and Its Clinical Value in the Diagnosis and Prognosis of Primary Aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121647
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Aldosteronism

Interventions

Gold Standard:Surgical pathology results and follow-up outcomes
Index test:[¹8F]Aldoview PET/CT

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old, regardless of gender; 2. Tolerable imaging agent injection; 3. PA confirmed by clinical diagnosis; 4. Adrenal vein blood collection or [68Ga]PentixaforPET/CT examination has been completed; 5. The patient and his family members were informed and signed the informed consent form, and were willing to cooperate in completing study-related examinations and follow-up.

Exclusion criteria

Exclusion criteria: 1. Presence of adrenal medulla disease or malignant tumor; 2. Failure to complete PET or post-follow-up; 3. Contraindications for PET imaging (such as claustrophobia, inability to cooperate in completing imaging examinations, etc.); 4. Other circumstances that the investigator deems inappropriate for inclusion in the study; 5. pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
specificity;sensitivity;Positive Predictive Value;Negative Predictive Value;Area under the ROC curve;

Countries

China

Contacts

Public ContactHua Pang

The First Affiliated Hospital of Chongqing Medical University

phua1973@163.com+86 23 8901 1714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026